December 4, 2017

Five Prime Therapeutics to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that Aron Knickerbocker, Chief Operating Officer, will present at the BMO Capital Markets Prescriptions for Success Healthcare Conference on Thursday, December 14, 2017 at 11:30am ETMr. Knickerbocker will become President and Chief Executive Officer of Five Prime on January 1, 2018.

The presentation will be webcast and may be accessed at the "Events & Presentations" section of the Company's website at http://investor.fiveprime.com/events.cfm or directly at https://cc.talkpoint.com/bmoc001/121417a_as/?entity=8_N6Q3JCG.  Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.   

About Five Prime
Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and late preclinical development. For more information, please visit www.fiveprime.com.

CONTACT
Derek Cole
Investor Relations Advisory Solutions
720-785-4497
derek.cole@iradvisory.com

Primary Logo

Source: Five Prime Therapeutics, Inc.

News Provided by Acquire Media


Close window | Back to top

Copyright 2017 Five Prime Therapeutics, Inc.